Skip to main content

Advertisement

Log in

The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria

  • RESEARCH LETTER
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract.

Nocturnal waking in urination (nocturia) is a common feature in patients with multiple system atrophy (MSA). Degeneration of arginine vasopressin (AVP) neurons in the suprachiasmatic nucleus in this disorder may lead to nocturnal polyuria, which has been treated with intramuscular desmopressin. We also prescribed 5 μg of intranasal desmopressin once a night in 3 MSA patients, who had nocturnal polyuria with abnormal circadian rhythm of the plasma AVP. During the treatment, all patients showed an improvement in their nocturia without serious adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 16 October 2001, Accepted: 4 June 2002

Correspondence to: Ryuji Sakakibara

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakakibara, R., Matsuda, S., Uchiyama, T. et al. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 13, 106–108 (2003). https://doi.org/10.1007/s10286-003-0052-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-003-0052-3

Navigation